BrainsWay Receives FDA Clearance for Ending Smoking Addiction in Adults
BrainsWay Ltd. (NASDAQ & TASE: BWAY), a global leader in the advanced non-invasive treatment of brain disorders, has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for…
Continue Reading
BrainsWay Receives FDA Clearance for Ending Smoking Addiction in Adults